Register Login
Register to leave comments
  • News bot Dec. 11, 2025, 9:07 p.m.

    📋 BiomX Inc. (PHGE) - Clinical Trial Update

    Filing Date: 2025-12-11

    Accepted: 2025-12-11 16:05:26

    Event Type: Clinical Trial Update

    Event Details:

    BiomX Inc. (PHGE) Announces Clinical Trial Update BiomX Inc. (PHGE) provided an update on its clinical development programs. Clinical Development Highlights:
    • Collaboration: Common Stock
    • Updated Timeline: 2025-12-11, December 11, 2025 BiomX Inc.

    🔬 Clinical Development Pipeline (BiomX Inc.):

    Product Type Development Stage Therapeutic Area Source
    Placebo OTHER Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    BX002-A BIOLOGICAL Phase PHASE1 Healthy Volunteers ClinicalTrials.gov
    BX005-A BIOLOGICAL Phase PHASE1 Atopic Dermatitis ClinicalTrials.gov
    BX004-A DRUG Phase PHASE1 Chronic Pseudomonas Aeruginosa Infection ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: BiomX Inc.
    • CIK: 0001739174
    • Ticker Symbol: PHGE
    • Period End Date: 2025-12-11
    • Document Type: 8-K

Search

News categories